Sante Capital Fund’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,636
Closed -$923K 57
2021
Q2
$923K Buy
+10,636
New +$923K 0.38% 73